Qualigen Therapeutics Inc (QLGN)
4.177
+0.25
(+6.28%)
USD |
NASDAQ |
Nov 13, 16:00
4.02
-0.16
(-3.75%)
After-Hours: 20:00
Qualigen Therapeutics Max Drawdown (5Y): 99.95% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.95% |
| September 30, 2024 | 99.94% |
| August 31, 2024 | 99.94% |
| July 31, 2024 | 99.94% |
| June 30, 2024 | 99.94% |
| May 31, 2024 | 99.91% |
| April 30, 2024 | 99.91% |
| March 31, 2024 | 99.91% |
| February 29, 2024 | 99.91% |
| January 31, 2024 | 99.91% |
| December 31, 2023 | 99.91% |
| November 30, 2023 | 99.91% |
| October 31, 2023 | 99.91% |
| September 30, 2023 | 99.91% |
| August 31, 2023 | 99.91% |
| July 31, 2023 | 99.91% |
| June 30, 2023 | 99.91% |
| May 31, 2023 | 99.91% |
| April 30, 2023 | 99.91% |
| March 31, 2023 | 99.91% |
| February 28, 2023 | 99.89% |
| January 31, 2023 | 99.89% |
| December 31, 2022 | 99.89% |
| November 30, 2022 | 99.89% |
| October 31, 2022 | 99.89% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.89% |
| August 31, 2022 | 99.89% |
| July 31, 2022 | 99.89% |
| June 30, 2022 | 99.89% |
| May 31, 2022 | 99.89% |
| April 30, 2022 | 99.89% |
| March 31, 2022 | 99.89% |
| February 28, 2022 | 99.89% |
| January 31, 2022 | 99.89% |
| December 31, 2021 | 99.89% |
| November 30, 2021 | 99.89% |
| October 31, 2021 | 99.87% |
| September 30, 2021 | 99.87% |
| August 31, 2021 | 99.87% |
| July 31, 2021 | 99.83% |
| June 30, 2021 | 99.83% |
| May 31, 2021 | 99.83% |
| April 30, 2021 | 99.80% |
| March 31, 2021 | 99.71% |
| February 28, 2021 | 99.69% |
| January 31, 2021 | 99.69% |
| December 31, 2020 | 99.69% |
| November 30, 2020 | 99.69% |
| October 31, 2020 | 99.69% |
| September 30, 2020 | 99.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.65%
Minimum
Nov 2019
99.95%
Maximum
Oct 2024
99.84%
Average
99.89%
Median
Nov 2021
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.78% |
| AIM ImmunoTech Inc | 99.61% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -65.51 |
| Beta (5Y) | -0.74 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 90.04% |
| Historical Sharpe Ratio (5Y) | -0.8337 |
| Historical Sortino (5Y) | -1.803 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.04% |